Association of airway inflammation with asthma control level evaluated by the asthma control test

Journal of Asthma

Volumn 48, Issue 9, 2011, Pages 907-913

  Shiota, Naoki ^a,b   Yokoyama, Akihito ^b   Haruta, Yoshinori ^a   Hattori, Noboru ^a   Kohno, Nobuoki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b KOCHI UNIVERSITY   (Japan)

Author keywords

Eosinophil; Induced sputum; Neutrophil; Nocturnal symptoms; Rescue use

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE;

ADULT; AGED; AIRWAY INFLAMMATION; ARTICLE; ASTHMA; ASTHMA CONTROL TEST; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE SEVERITY; EOSINOPHIL; EOSINOPHIL COUNT; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; NEUTROPHIL COUNT; QUESTIONNAIRE; SPUTUM;

ADULT; AGED; ASTHMA; EOSINOPHILS; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NEUTROPHILS; QUESTIONNAIRES; RESPIRATORY SYSTEM;

EID: 80054953463     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770903.2011.615430     Document Type: Article

References (33)

1. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. Updated 2009. Available at: http:// www.ginasthma.org /Guidelineitem.asp l1=2&l2=1&intId=1561. Accessed March 8, 2011
2. Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, Murray JJ, Pendergraft TB. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 2004; 113:59-65
3. Lundback B, Dahl R. Assessment of asthma control and its impact on optimal treatment strategy. Allergy 2007; 62:611-619
4. Schatz M, Sorkness CA, Li JT, Marcus P, Murray JJ, Nathan RA, Kosinski M, Pendergraft TB, Jhingran P. Asthma control test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol 2006; 117:549-556
5. Halbert RJ, Tikelman DG, Globe DR, Lin SL. Measuring asthma control is the first step to management: a literature review. J Asthma 2009; 46:659-664
6. Revicki D, Weiss KB. Clinical assessment of asthma symptom control: review of current assessment instruments. J Asthma 2006; 43:481-487
7. Leuppi JD, Salome CM, Jenkins CR, Anderson SD, Xuan W, Marks GB, Koskela H, Brannan JD, Freed R, Andersson M, Chan HK, Woolcock AJ. Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids. Am J Respir Crit Care Med 2001; 163:406-412
8. Pizzichini MM, Pizzichini E, Clelland L, Efthimiadis I, Pavord J, Dolovich J, Hargreave FE. Prednisone-dependent asthma: inflammatory indices in induced sputum. Eur Respir J 1999; 13:15-21
9. Deykin A, Lazarus SC, Fahy JV,Wechsler ME, Boushey HA, Chinchilli VM, Craig TJ, Dimango E, Kraft M, Leone F, Lemanske RF, Martin RJ, Pesola GR, Peters SP, Sorkness CA, Szefler SJ, Israel E. Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids. J Allergy Clin Immunol 2005; 115:720-727
10. Jatakanon A, Lim S, Barnes PJ. Changes in sputum eosinophils predict loss of asthma control. Am J Respir Crit Care Med 2000; 161:64-72
11. Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P, Wardlaw AJ, Pavord ID. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002; 360:1715-1721
12. Jayaram L, Pizzichini MM, Cook RJ, Boulet LP, Lemiere C, Pizzichini E, Cartier A, Hussack P, Goldsmith CH, Laviolette M, Parameswaran K, Hargreave FE. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J 2006; 27:483-494
13. Chlumsky J, Striz I, TerlM, Vondracek J. Strategy aimed at reduction of sputum eosinophils decreases exacerbation rate in patients with asthma. J Int Med Res 2006; 34:129-139
14. Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet 2006; 368:804-813
15. Wenzel SE, Szefler SJ, Leung DYM, Sloan SI, Rex MD, Martin RJ. Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med 1997; 156:737-743
16. Woodruff PG, Khashayar R, Lazarus SC, Janson S, Avila P, Boushey HA, Segal M, Fahy JV. Relationship between airway inflammation, hyperresponsiveness, and obstruction in asthma. J Allergy Clin Immunol 2001; 108:753-758
17. Shaw DE, Berry MA, Hargadon B, McKenna S, Shelly MJ, Green RH, Brightling CE, Wardlaw AJ, Pavord ID. Association between neutrophilic airway inflammation and airflow limitation in adults with asthma. Chest 2007; 132:1871-1875
18. Simpson JL, Milne DG, Hibson PG. Neutrophilic asthma has different radiographic features to COPD and smokers. Respir Med 2009; 103:881-887
19. Gelfand EW, Kraft M. The importance and features of the distal airways in children and adults. J Allergy Clin Immunol 2009; 124(6 Suppl.):S84-S87
20. Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, Casale TB, Chanez P, Enright PL, Gibson PG, de Jongste JC, Kerstjens HA, Lazarus SC, Levy ML, OByrne PM, Partridge MR, Pavord ID, Sears MR, Sterk PJ, Stoloff SW, Sullivan SD, Szefler SJ, Thomas MD, Wenzel SE. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations. Am J Respir Crit Care Med 2009; 180:59-99
21. American Thoracic Society. Standardization of spirometry: 1994 update. Am J Respir Crit Care Med 1995; 152:2185-2198
22. Efthimiadis A, Spanevello A, Hamid Q, Kelly MM, LindenM, Louis R, Pizzichini MM, Pizzichini E, Ronchi C, Van Overvel F, Djunkanovic R. Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation. Eur Respir J 2002; 37 (Suppl.):S19-S23
23. Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, Casale TB, Chanez P, Enright PL, Gibson PG, de Jongste JC, Kerstjens HA, Lazarus SC, Levy ML, OByrne PM, Partridge MR, Pavord ID, Sears MR, Sterk PJ, Stoloff SW, Szefler SJ, Sullivan SD, Thomas MD, Wenzel SE, Reddel HK. A new perspective on concepts of asthma severity and control. Eur Respir J 2008; 32:545-554
24. Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJH, Pauwels RA, Pedersen SE. Can guideline-defined asthma control be achieved? Am J Respir Crit Care Med 2004; 170:836-844
25. Haldar P, Pavord IP. Noneosinophilic asthma: a distinct clinical and pathologic phenotype. J Allergy Clin Immunol 2007; 119: 1043-1052
26. Hadlar P, Pavord ID, Shaw DE, Berry MA, Thomas M, Brightling CE, Wardlaw AJ, Green RH. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 2008; 178:218-224
27. Martin RJ. Therapeutic significance of distal airway inflammation in asthma. J Allergy Clin Immunol 2002; 109(2 Suppl.):S447-S460
28. Simpson JL, Scott R, Boyle MJ, Gibson PG. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology 2006; 11:54-61
29. Tomson NC, Chaudhuri R, Livingston E. Asthma and cigarette smoking. Eur Respir J 2004; 24:822-833
30. Broekema M, Hacken NHT, Volbeda F, Lodewijk ME, Hylkema MN, Postma DS. Airway epithelial changes in smokers but not in ex-smokers with asthma. Am J Respir Crit Care Med 2009; 180:1170-1178
31. Mcleish AC, Zvolensky MJ. Asthma and cigarette smoking: a review of the empirical literature. J Asthma 2010; 47:345-361
32. Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax 2009; 64: 728-735
33. Di Lorenzo G, Mansueto P, Ditta V, Esposito-PellitteriM, Lo Bianco C, Leto Barone MS, DAlcamo A, Farina C, Di Fede G, Gervasi F, Caruso C, Rini G. Similarity and differences in elderly patients with fixed airflow obstruction by asthma and by chronic obstructive pulmonary disease. Respir Med 2008; 102:232-238